ArticleAntimicrobial agents and chemotherapy2022

Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing

Juan Carlos Vázquez-Ucha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.